You Can Help
Contact
Forum
Shop
Search
Sign Up
Donate
You Can Help
What is ALS
Newly Diagnosed?
Treatments & ALS Drugs
Frequently Asked Questions
Glossary
ALS Research
Drug Discovery Engine
ALS Research Collaborative
ARC Data Commons
Research News
Meet Our Scientists
Translational Research
Explore Our Lab
Publications
Help Fund Treatments
Donate
Start a Fundraiser
Events
ALS Awareness
Other Ways to Give
Corporate Opportunities
Resources
ALS Forum
ALS Clinical Trials
News
ALS Town Hall
ALS TDI Community Conversations
ALS Unfiltered
Podcasts
About Us
History
Team
Our Supporters
Schedule a Tour
Financials
Press Room
Contact Us
You Can Help
Contact
Forum
Search
Donate
Sign Up
Your support fuels our research to #EndALS!
Donate Now
News & Resources
>
Blog Articles
>
Article
Proudly Reflecting on ALS Research in 2020
December 29, 2020
Share
A letter from the ALS Therapy Development Institute's (
ALS TDI
) Chief Scientific Officer, Fernando Vieira M.D.
Dear ALS Community,
Happy holidays and thank you for continuing to support our mission to end ALS.
The past year has been unique in so many ways.
Certainly, we have all confronted uncertainties and hardships.
But 2020 has been unique in positive ways as well.
I have been deeply inspired to see the team of scientists at ALS TDI persevere through the year – adapting to new safety protocols, working odd hours, adjusting to working from home, and pivoting on projects to advance our mission as quickly as possible.
In speaking with members of the science team throughout the year, I heard a consistent refrain:
any challenges our scientists have faced were negligible compared to the challenges of the people with ALS who we aim to serve.
And so, thanks to your unwavering support, your team of scientists at ALS TDI accomplished our goals in 2020.
I’d like to share some highlights with you here.
We began a drug screening initiative
testing our library of 36,000 small molecules using neural cells derived from human induced pluripotent stem cells.
We have begun lead discovery assessments of early hits
from the drug screening campaign using in vivo models with promising molecules emerging.
We have been analyzing blood samples
from the Precision Medicine Program’s (PMP) In-Home Blood Collection Initiative to discover and validate blood-based biomarkers of ALS disease progression.
We enrolled more than 85 new participants into the PMP
to allow for the comprehensive study of ALS symptom progression, genetics, risk factors, biomarkers, and outcomes from interventions.
We
published a paper
in Frontiers in Pharmacology
where we shared our discovery of a previously unexplored drug target for C9ORF72-mediated ALS.
I am so proud of what we accomplished in 2020 despite the circumstances, but it would be disingenuous for me to say that we moved as quickly as I had hoped.
I am excited to seize on the opportunities that we have created through our recent discoveries, I am inspired by the team of scientists that I get to be a part of, and I am buoyed by the support of the ALS community and your faith in us.
I look forward to sharing our continued progress with you.
This is your lab, and we will continue our relentless research for all of you.
With sincere gratitude,
Fernando Vieira, M.D., CSO
The ALS Therapy Development Institute
If you would like to make a donation to support our ALS research, please
click here
.
ALS is not an incurable disease.
It is an underfunded disease.
Subscribe
Sign up
to receive updates about the latest ALS research, ALS TDI's work, and the community.
Stay Informed
Related Reading
ALS vs Lyme Disease
Read more
Lynne Nieto: ALS TDI’s New Board Chair Aims to Carry on Her Late Husband's Legacy
Read more
Relationships and ALS – A Young Faces of ALS Town Hall Series
Read more
Follow Us
Learn more about our team, what we're working on in the lab, and our amazing community by following us on social media!
Author:
Fernando Vieira
Talk with Us
Whether you have questions about research, resources, clinical trials, or just want to connect and have a conversation,
we want to hear from you.
Let us help
Follow Us
Learn more about our team, what we're working on in the lab, and our amazing community by following us on social media!
Subscribe
Sign up
to receive updates about the latest ALS research, ALS TDI's work, and the community
Stay Informed
Related Reading
ALS vs Lyme Disease
Read more
Lynne Nieto: ALS TDI’s New Board Chair Aims to Carry on Her Late Husband's Legacy
Read more
Relationships and ALS – A Young Faces of ALS Town Hall Series
Read more
×
Share To
Can we help you?
Enter details below if you would like a member
of the ALS TDI team to contact you.
{{errorMessage}}
First Name
Last Name
Email
Phone
State
Select a State
Country
Select a Country
How would you like to be contacted
Email
Phone
I am (relation to ALS)
Select a relation to ALS
relation to ALS is required
too many characters entered
Please specify
relation to als other is required
too many characters entered
Please provide additional details so that a
member of the ALS TDI team can assist you.
Submit
What is ALS
ALS Research
Help Fund Treatments
Resources
About Us
Contact
Forum
Shop
Search
Donate
Sign Up
What is ALS
Overview
Newly Diagnosed?
Treatments & ALS Drugs
FAQS
Glossary
Contact
Forum
Shop
Search
Donate
Sign Up
ALS Research
Overview
Drug Discovery Engine
ALS Research Collaborative
ARC Data Commons
Research News
Meet Our Scientists
Translational Research
Explore Our Lab
Publications
Contact
Forum
Shop
Search
Donate
Sign Up
Help Fund Treatments
Overview
Donate
Start a Fundraiser
Events
ALS Awareness
Other Ways To Give
Corporate Opportunities
Contact
Forum
Shop
Search
Donate
Sign Up
Resources
Overview
ALS Forum
ALS Clinical Trials
News
ALS Town Hall
ALS TDI Community Conversations
ALS Unfiltered
Podcasts
Contact
Forum
Shop
Search
Donate
Sign Up
About Us
Overview
History
Team
Our Supporters
Schedule a Tour
Financials
Press Room
Contact Us
Contact
Forum
Shop
Search
Donate
Sign Up
Cookie Declaration
×